SEC Tracker
Get the app

Propanc Biopharma PPCB

Propanc Biopharma: quarterly report for the quarter ended Sep 30, 2017

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 4.10
Warrants or notes
Exhibit 4.11
Warrants or notes
Exhibit 4.12
Warrants or notes
Exhibit 10.7
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Propanc Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cannapharmarx CPMD public float $3M, Jun 30, 2025
  2. MetaVia MTVA public float $3M, Jun 30, 2025
  3. Oragenics OGEN public float $3M, Jun 30, 2025
  4. Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
  5. PTC Therapeutics PTCT public float $3M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.